-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Vitro Biopharma, Inc. quarterly Deferred Tax Assets, Gross history and change rate from Q3 2012 to Q3 2024.
- Vitro Biopharma, Inc. Deferred Tax Assets, Gross for the quarter ending 31 Oct 2024 was $7.44M, a 47.3% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)